Vivendal Comp 160 mg/12,5 mg Filmdragerad tablett

Država: Švedska

Jezik: švedski

Izvor: Läkemedelsverket (Medical Products Agency)

Kupi sada

Uputa o lijeku Uputa o lijeku (PIL)
22-04-2018
Svojstava lijeka Svojstava lijeka (SPC)
22-04-2018

Aktivni sastojci:

hydroklortiazid; valsartan

Dostupno od:

Sandoz A/S

ATC koda:

C09DA03

INN (International ime):

hydrochlorothiazide; valsartan

Doziranje:

160 mg/12,5 mg

Farmaceutski oblik:

Filmdragerad tablett

Sastav:

valsartan 160 mg Aktiv substans; hydroklortiazid 12,5 mg Aktiv substans

Razred:

Apotek

Tip recepta:

Receptbelagt

Područje terapije:

Valsartan och diuretika

Proizvod sažetak:

Förpacknings: Blister, 7 tabletter (plast/Al); Blister, 7 tabletter (Al); Blister, 10 tabletter (Al); Blister, 14 tabletter (Al); Blister, 15 tabletter (Al); Blister, 20 tabletter (Al); Blister, 28 tabletter (Al); Blister, 30 tabletter (Al); Blister, 50 tabletter (Al); Blister, 56 tabletter (Al); Blister, 60 tabletter (Al); Blister, 84 tabletter (Al); Blister, 90 tabletter (Al); Blister, 98 tabletter (Al); Blister, 100 tabletter (Al); Blister, 280 tabletter (Al); Blister, 10 tabletter (plast/Al); Blister, 14 tabletter (plast/Al); Blister, 15 tabletter (plast/Al); Blister, 20 tabletter (plast/Al); Blister, 28 tabletter (plast/Al); Blister, 30 tabletter (plast/Al); Blister, 50 tabletter (plast/Al); Blister, 56 tabletter (plast/Al); Blister, 60 tabletter (plast/Al); Blister, 84 tabletter (plast/Al); Blister, 90 tabletter (plast/Al); Blister, 98 tabletter (plast/Al); Blister, 100 tabletter (plast/Al); Blister, 280 tabletter (plast/Al); Blister, 50 x 1 tabletter, endos (Al); Blister, 50 x 1 tabletter, endos (plast/Al)

Status autorizacije:

Godkänd

Datum autorizacije:

2011-04-15

Uputa o lijeku

                                PACKAGE LEAFLET: INFORMATION FOR THE USER
Vivendal Comp 80 mg /12.5 mg film-coated tablets
Vivendal Comp 160 mg /12.5 mg film-coated tablets
Vivendal Comp 160 mg /25 mg film-coated tablets
Vivendal Comp 320 mg /12.5 mg film-coated tablets
Vivendal Comp 320 mg /25 mg film-coated tablets
Valsartan/hydrochlorothiazide
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Vivendal Comp is and what it is used for
2.
What you need to know before you take Vivendal Comp
3.
How to take Vivendal Comp
4.
Possible side effects
5.
How to store Vivendal Comp
6.
Contents of the pack and other information
1.
WHAT VIVENDAL COMP IS AND WHAT IT IS USED FOR
Vivendal Comp film-coated tablets contain two active substances called
valsartan and
hydrochlorothiazide. Both of these substances help to control high
blood pressure (hypertension).

VALSARTAN belongs to a class of medicines known as “angiotensin II
receptor antagonists”,
which help to control high blood pressure. Angiotensin II is a
substance in the body that
causes vessels to tighten, thus causing your blood pressure to
increase. Valsartan works by
blocking the effect of angiotensin II. As a result, blood vessels
relax and blood pressure is
lowered.

HYDROCHLOROTHIAZIDE belongs to a group of medicines called thiazide
diuretics (also
known as “water tablets”). Hydrochlorothiazide increases urine
output, which also lowers
blood pressure.
Vivendal Comp is used to treat high blood pressure which is not
adequately controlled by a single
substance a
                                
                                Pročitajte cijeli dokument
                                
                            

Svojstava lijeka

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Pročitajte cijeli dokument
                                
                            

Dokumenti na drugim jezicima

Uputa o lijeku Uputa o lijeku engleski 18-03-2022
Svojstava lijeka Svojstava lijeka engleski 16-01-2019
Izvješće o ocjeni javnog Izvješće o ocjeni javnog engleski 21-02-2013